Skip to main content
ILDONG HOLDINGS CO.,LTD  logo

ILDONG HOLDINGS CO.,LTD — Investor Relations & Filings

Ticker · 000230 ISIN · KR7000230003 KO Manufacturing
Filings indexed 368 across all filing types
Latest filing 2024-07-19 Capital/Financing Update
Country KR South Korea
Listing KO 000230

About ILDONG HOLDINGS CO.,LTD

https://www.ildongholdings.com

ILDONG HOLDINGS CO.,LTD. is a holding company that manages a diversified healthcare group. Its primary subsidiary, Ildong Pharmaceutical, develops, manufactures, and supplies a broad portfolio of pharmaceutical products, including over-the-counter drugs, vitamins, and antibiotics. The pharmaceutical division maintains a robust R&D pipeline focused on treating metabolic disorders, gastrointestinal diseases, and degenerative conditions. Other key subsidiaries include ILDONG BIOSCIENCE, a specialist in probiotics and functional health foods, and Ildong Healthcare, which provides healthy-lifestyle products such as water ionization units. The group collectively aims to enhance human health through its diverse offerings in pharmaceuticals, bioscience, and consumer healthcare.

Recent filings

Filing Released Lang Actions
타인에대한담보제공결정
Capital/Financing Update Classification · 100% confidence The document is a formal regulatory disclosure regarding a 'Decision to Provide Collateral to Others' (타인에 대한 담보제공 결정) filed by Ildong Holdings. It details the collateral provided for a subsidiary's debt, including the creditor, amount, and board resolution details. As this is a specific regulatory disclosure regarding corporate financing and collateral, and does not fit into the other specific categories like M&A or Share Issues, it falls under the general regulatory filing category.
2024-07-19 Korean
[기재정정]타인에대한담보제공결정
Capital/Financing Update Classification · 100% confidence The document is a regulatory filing from Ildong Holdings regarding a 'Decision to Provide Collateral for Others' (타인에대한담보제공결정). It details a correction to a previous filing concerning collateral provided for a subsidiary, Ildong Pharmaceutical. Since this is a specific regulatory disclosure regarding corporate financial activities (collateral/guarantees) that does not fit into categories like M&A, dividends, or share issues, it falls under the 'Regulatory Filings' (RNS) category as the appropriate fallback.
2024-07-19 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서), which is a regulatory filing required under the Capital Markets Act in South Korea when an individual or entity acquires a significant stake in a company. This document details the shareholding status, changes in ownership (including insider trades), and the purpose of the holding (influencing management). It fits the definition of a 'Major Shareholding Notification' (MRQ) as it tracks changes in significant ownership levels.
2024-07-04 Korean
최대주주등소유주식변동신고서
Director's Dealing Classification · 100% confidence The document is a '최대주주등소유주식변동신고서' (Report of Change in Shareholding by Major Shareholders and Related Parties) for Ildong Holdings. It details specific share transactions (장내매수 - open market purchase) by an executive (Choi Gyu-hwan) and provides a comprehensive table of share ownership for major shareholders and related parties. This falls under the category of Director's Dealing (DIRS) as it reports personal share transactions by company executives and major shareholders.
2024-07-04 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. This type of filing is a mandatory disclosure by company insiders (directors/executives) regarding their personal share transactions (insider trading). Based on the provided definitions, this falls under 'Director's Dealing'.
2024-07-04 Korean
기업지배구조보고서공시
Governance Information Classification · 100% confidence The document is a 'Corporate Governance Report' (기업지배구조보고서) for Ildong Holdings. It details the company's governance structure, shareholder rights, board composition, and internal control policies. This type of report is a standard regulatory filing in South Korea, specifically categorized under Corporate Governance Reports (CGR).
2024-05-31 Korean

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.